NCT07013669

Brief Summary

The study summary and design were to assess procedural anxiety and stress in parents and pain perception in children during intradermal testing. Music medicine was incorporated into the study design as a nonpharmacological intervention. Two distinct auditory modalities were used: solfeggio frequencies-174 Hz, 285 Hz, 396 Hz, and 528 Hz-which have been suggested to interact with the human energy field through resonance-based mechanisms, and Turkish classical musical modes (makams), such as Rast, Hicaz, Uşşak, Neva, and Saba, which are modal systems that include microtonal intervals and follow specific melodic progressions that are often associated with different emotional and spiritual effects as well as sensory and emotional regulation potential.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 14, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

May 21, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 10, 2025

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 6, 2025

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 14, 2025

Completed
Last Updated

December 8, 2025

Status Verified

December 1, 2025

Enrollment Period

2 months

First QC Date

May 21, 2025

Last Update Submit

December 2, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Parental State Anxiety Levels

    Change in parental state anxiety will be assessed using the State-Trait Anxiety Inventory - State Subscale (STAI-S). The STAI-S is a validated psychological inventory that measures current levels of anxiety. It consists of 20 items, each rated on a 4-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate greater levels of anxiety. STAI-S scores will be collected immediately before and immediately after the intradermal testing (IDT) procedure. The change in anxiety levels will be calculated as the difference between post-procedure and pre-procedure scores (ΔSTAI-S), and will be used to evaluate the effect of the intervention.

    within 5 minutes before and post procedure

  • Pain Levels in Pediatric Patients During Intradermal Testing

    Pain scores will be evaluated immediately after the intradermal testing (IDT) procedure. For children under 5 years of age, pain will be assessed using the Children's Hospital of Eastern Ontario Pain Scale (CHEOPS). This is a behavioral pain assessment tool with scores ranging from 4 to 13, where higher scores indicate greater pain. For children aged 5 years and older, pain will be assessed using the Wong-Baker FACES Pain Rating Scale. This self-report scale ranges from 0 to 10, where higher scores indicate greater pain.

    within 2 minutes post-procedure

Study Arms (3)

Control Group

NO INTERVENTION

Participants undergo standard intradermal testing (IDT) without any additional auditory intervention

Solfeggio Music Intervention

EXPERIMENTAL

Participants receive receptive music therapy using Solfeggio frequencies (174 Hz, 285 Hz, 396 Hz, and 528 Hz) during the IDT procedure. Music starts five minutes before and continues throughout the procedure

Behavioral: Receptive Music Therapy - Solfeggio Frequencies

Traditional Turkish Music Intervention

EXPERIMENTAL

Participants receive receptive music therapy using selected Traditional Turkish Music modes (makams), including Rast, Hicaz, Uşşak, Neva, and Saba, during the IDT procedure. Music starts five minutes before and continues throughout the procedure

Behavioral: Receptive Music Therapy - Traditional Turkish Music

Interventions

Music featuring Solfeggio frequencies (174 Hz, 285 Hz, 396 Hz, 528 Hz) is played through standardized speakers in a sound-isolated room during IDT. Duration includes five minutes before and throughout the procedure

Solfeggio Music Intervention

Selected Turkish Classical Music pieces (makams: Rast, Hicaz, Uşşak, Neva, Saba) are played via speakers in a sound-isolated room during IDT. Music begins five minutes prior and continues during the procedure.

Traditional Turkish Music Intervention

Eligibility Criteria

Age2 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Children aged between 2 and 17 years
  • Referred to the Pediatric Allergy Clinic for evaluation of suspected drug hypersensitivity reactions
  • Accompanied by a parent or legal guardian willing to participate
  • Written informed consent obtained from parents or legal guardians

You may not qualify if:

  • Known neurological, psychiatric, or developmental disorders in the child
  • Use of sedatives or analgesic medications within 24 hours prior to testing
  • Hearing impairment or auditory processing disorders in the child4.Non-consent or withdrawal of consent by parent or guardian
  • Inability of the parent to complete anxiety assessments (e.g., due to language or cognitive barriers)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prof Dr Cemil Tascioglu Education and Research Hospital Organization

Istanbul, Şişli, 34360, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Anxiety DisordersAgnosia

Condition Hierarchy (Ancestors)

Mental DisordersPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical Doctor, Pediatric Allergy and Immunology

Study Record Dates

First Submitted

May 21, 2025

First Posted

June 10, 2025

Study Start

May 14, 2025

Primary Completion

July 6, 2025

Study Completion

July 14, 2025

Last Updated

December 8, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Identified individual participant data (IPD) that underlie the results reported in this article will be shared. This includes:Demographic information (age, sex, parental education level)Baseline clinical data (allergy history, suspected drug, clinical symptoms)Pre- and post-intervention STAI scores (State and Trait Anxiety Inventory)Pain scores measured using CHEOPS and Wong-Baker FACES scalesGroup allocation (Control, Solfeggio, Traditional Turkish Music)All shared data will be anonymized to protect participant confidentiality.

Shared Documents
STUDY PROTOCOL

Locations